Phillip J. Buckhaults
Affiliations: | Drug Discovery & Biomedical Sciences | University of South Carolina, Columbia, SC |
Google:
"Phillip Buckhaults"
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Khalili S, Mohseninia A, Liu C, et al. (2025) Comprehensive genomic dependency landscape of a human colon cancer organoid. Communications Biology. 8: 436 |
| Massey JC, Magagnoli J, Sutton SS, et al. (2024) Collateral damage of NUDT15 deficiency in cancer provides a cancer pharmacogenetic therapeutic window with thiopurines. Biorxiv : the Preprint Server For Biology |
| Vu T, Datta A, Banister C, et al. (2021) STRAP is a Critical Mediator of APC Mutation-Induced Intestinal Tumorigenesis through a Feed-Forward Mechanism. Gastroenterology |
| Hofseth LJ, Hebert JR, Chanda A, et al. (2020) Publisher Correction: Early-onset colorectal cancer: initial clues and current views. Nature Reviews. Gastroenterology & Hepatology |
| Saatci O, Kaymak A, Raza U, et al. (2020) Targeting lysyl oxidase (LOX) overcomes chemotherapy resistance in triple negative breast cancer. Nature Communications. 11: 2416 |
| Kundu A, Nam H, Shelar S, et al. (2020) PRDM16 suppresses HIF-targeted gene expression in kidney cancer. The Journal of Experimental Medicine. 217 |
| Hofseth LJ, Hebert JR, Chanda A, et al. (2020) Early-onset colorectal cancer: initial clues and current views. Nature Reviews. Gastroenterology & Hepatology |
| Makena MR, Dang D, Mekile A, et al. (2020) Abstract 5276: Secretory pathway calcium ATPase 2 (SPCA2) promotes cell survival and chemoresistance in receptor positive breast cancer cells Cancer Research. 80: 5276-5276 |
| Dwyer AJ, Murphy CC, Boland CR, et al. (2019) A summary of the Fight Colorectal Cancer working meeting: exploring risk factors and etiology of sporadic early-age onset colorectal cancer. Gastroenterology |
| Liu C, Banister CE, Buckhaults PJ. (2019) Spindle assembly checkpoint inhibition can resensitize p53-null stem cells to cancer chemotherapy. Cancer Research |